Analyst, Global Health & Antimicrobial Resistance at IQVIA

London, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Life Sciences, Global HealthIndustries

Requirements

MA/MSc from a top university, preferably in a relevant subject such as public health, medicine, life sciences, economics, or epidemiology
Knowledge and experience of core epidemiological concepts
Experience working in global or public health, with understanding of key issues and current developments in the global health ecosystem (preferable)
Knowledge of antimicrobial resistance (preferable)
Data processing and analytical skills
Strong organisational skills
Collaborative approach to work
Problem-solving attitude, anticipating issues early, analysing, interpreting, and solving them proactively
Curiosity for developing and interpreting new insights, and ability to articulate the added value these bring to clients and collaborators
Excellent conversational and business English (written and oral); additional languages are an advantage
Willingness and ability to travel

Responsibilities

Support the coordination of IQVIA’s AMR Centre of Excellence and its strategic initiatives
Analyze and interpret data from IQVIA and other sources to inform AMR strategies at national and global levels
Act as a translator between industry, health systems, and global health, ensuring clarity and collaboration
Contribute to IQVIA’s global public health strategy, aligning AMR work with broader objectives
Collaborate with internal and external stakeholders, fostering partnerships that drive meaningful impact

Skills

epidemiology

data analysis

data processing

public health

antimicrobial resistance

stakeholder collaboration

problem-solving

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free